Literature DB >> 21569112

Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities.

C Léauté-Labrèze1, S Prey, K Ezzedine.   

Abstract

Infantile haemangioma (IH) is the most common tumour of infancy. Its typical natural history is characterized by an early rapid growth following birth and a slow spontaneous regression phase within a period of 3 to 7 years. The exact aetiopathogeny underlying IH is still to be fully understood, but the role of fetal hypoxic stress is strongly suggested as a triggering signal in epidemiological studies. IH are composed of a complex mixture of cells including multipotent stem cells, a majority of immature endothelial cells, pericytes, dendritic cells and in the late stage, adipocytes. Most of IH are nodular and are not associated with malformations. However, in some cases, IH referred to as segmental may be associated with developmental abnormalities such as PHACES and PELVIS/SACRAL syndromes.
© 2011 The Authors. Journal of the European Academy of Dermatology and Venereology © 2011 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2011        PMID: 21569112     DOI: 10.1111/j.1468-3083.2011.04102.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  23 in total

Review 1.  Educational paper: Pathogenesis of infantile haemangioma, an update 2014 (part I).

Authors:  Sherief R Janmohamed; Gerard C Madern; Peter C J de Laat; Arnold P Oranje
Journal:  Eur J Pediatr       Date:  2014-08-26       Impact factor: 3.183

2.  Multifocal infantile haemangioma: a diagnostic challenge.

Authors:  Erica Torres; João Rosa; Christine Leaute-Labreze; Luis Soares-de-Almeida
Journal:  BMJ Case Rep       Date:  2016-06-17

3.  Long noncoding RNA expression profile of infantile hemangioma identified by microarray analysis.

Authors:  Xiaowen Liu; Renrong Lv; Linfeng Zhang; Guangqi Xu; Jianhai Bi; Feng Gao; Jian Zhang; Feng Xue; Fagang Wang; Yiliang Wu; Cong Fu; Qiang Wang; Ran Huo
Journal:  Tumour Biol       Date:  2016-10-05

4.  Negative pressure wound therapy in the treatment of ulcerated infantile haemangioma.

Authors:  Carly M Fox; Bethan Johnson; Kristen Storey; Romi Das Gupta; Roy Kimble
Journal:  Pediatr Surg Int       Date:  2015-05-13       Impact factor: 1.827

5.  Treatment failure with propranolol for subglottic haemangioma.

Authors:  Zhaobo Liu; Yen Huan Yeo; Conor Jackson; Keith Trimble
Journal:  BMJ Case Rep       Date:  2019-05-13

6.  Timing and Efficacy of 595-nm Pulsed-Dye Laser Combined with 0.5% Timolol Maleate Solution in the Treatment of Superficial Infantile Hemangiomas.

Authors:  Weikang Shi; Huiyi He; Jicong Jiang; Yu Gao; Hehe Quan
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-02

7.  Propranolol inhibits angiogenesis via down-regulating the expression of vascular endothelial growth factor in hemangioma derived stem cell.

Authors:  Ling Zhang; Hua-Ming Mai; Jing Zheng; Jia-Wei Zheng; Yan-An Wang; Zhong-Ping Qin; Ke-Lei Li
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Pharmacological therapies for infantile hemangiomas: A clinical study in 853 consecutive patients using a standard treatment algorithm.

Authors:  Ling Zhang; Wei-En Yuan; Jia-Wei Zheng
Journal:  Sci Rep       Date:  2016-02-15       Impact factor: 4.379

Review 9.  Propranolol in use for treatment of complex infant hemangiomas: literature review regarding current guidelines for preassessment and standards of care before initiation of therapy.

Authors:  Andreas Fette
Journal:  ScientificWorldJournal       Date:  2013-05-20

10.  Effects of propranolol and isoproterenol on infantile hemangioma endothelial cells in vitro.

Authors:  Yalin Zhu; Aerziguli Tuerxun; Yan Hui; Paride Abliz
Journal:  Exp Ther Med       Date:  2014-06-12       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.